Combined therapy [topp]
Hormonal [qlco]
Post-Menopause [orgf]
Women [popg]
Study [mnob]
effects [qlco]
Hormone replacement therapy [topp]
Combination [qlco]
Estradiol [horm, phsu, strd]
drospirenone [orch, phsu]
Subclinical [qlco]
vascular [bpoc]
Pathology [bmod]
Women [popg]
Post-Menopause [orgf]
Material [sbst]
Methods [inpr]
Women [popg]
Post-Menopause [orgf]
GIVEN [cnce]
Informed Consent [rnlw]
Standard [qlco]
divided [ftcn]
Group [idcn]
Group I [inpr]
Gynaecologist [prog]
confirmed [qlco]
Indications [idcn]
Hormone replacement therapy [topp]
Angeliq [horm, phsu, strd]
mg% [qnco]
17 beta-Estradiol [horm, phsu, strd]
mg% [qnco]
drospirenone [orch, phsu]
Group [idcn]
Ii [aapp]
Hormone replacement therapy [topp]
participants [popg]
Assessment [hlca]
Metabolic [ftcn]
Parameters [fndg]
Obesity, Visceral [sosy]
Intima media thickness [clna]
Common Carotid Arteries [bpoc]
Arterial Stiffness [phsf]
Microcirculation [ortf]
Status [qlco]
baseline [bodm]
months [tmco]
Hormone replacement therapy [topp]
effects [qlco]
Autonomic [bdsy]
Regulation [gora]
Lipid Metabolism [moft]
Common Carotid Arteries [bpoc]
Intima media thickness [clna]
Arterial Stiffness [phsf]
reduction [npop]
Obesity, Visceral [sosy]
Antihypertensive [phsu]
Microcirculation [ortf]
Dilatation [topp]
Reserve [acty]
postmenopausal [tmco]
Women [popg]
Low dose [qnco]
Combined [qlco]
Hormone Therapy [topp]
drospirenone [orch, phsu]
Estradiol [horm, phsu, strd]
Recommended [idcn]
Specific [qlco]
Group [idcn]
Women [popg]
Post-Menopause [orgf]
